September 06, 2025 a 09:00 am
CNC: Analysts Ratings - Centene Corporation
Centene Corporation operates within a multifaceted healthcare landscape, providing services primarily to under-insured and uninsured individuals. The company's focus on government-subsidized programs makes it a crucial partner in healthcare services. Recent analyst ratings indicate a shift towards more cautiousness, perhaps a reflection of market uncertainty.
Historical Stock Grades
As of September 2025, CNC has experienced a notable downward shift in analyst optimism over the recent months. The total number of ratings has remained stable, but a clear trend toward more conservative estimates is evident.
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 4 | |
| Hold | 13 | |
| Sell | 0 | |
| Strong Sell | 1 |
Sentiment Development
Over the past months, sentiment towards Centene Corporation has experienced noticeable changes. Analysts have shifted their positions from a previously more optimistic viewpoint.
- Strong Buy ratings have notably decreased, indicating a reduction in firm convictions for upside potential.
- Hold recommendations have increased, reflecting a neutral stance amidst uncertain market conditions.
- Overall, the cautious sentiment reveals an increase in market hesitance regarding Centene's stock performance.
Percentage Trends
In recent months, the distribution of analyst ratings has demonstrated a clear shift away from strong buy positions. This movement appears to coincide with overall market trends that prioritize conservatism.
- Buy ratings decreased from 28% to under 20%.
- Hold ratings increased from over 50% to nearly two-thirds of all recommendations.
- This trend suggests a prudent market outlook, with analysts adopting a wait-and-see approach.
Latest Analyst Recommendations
Recent analyst updates demonstrate consistency in moderate recommendations for Centene Corporation. Current ratings retain a cautious approach with prevailing neutral terms.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-09-05 | Outperform | Outperform | Bernstein |
| 2025-09-04 | Equal Weight | Equal Weight | Barclays |
| 2025-08-26 | Neutral | Neutral | Cantor Fitzgerald |
| 2025-08-04 | Equal Weight | Equal Weight | Morgan Stanley |
| 2025-07-29 | Neutral | Neutral | JP Morgan |
Analyst Recommendations with Change of Opinion
Recent downgrades indicate a growing caution among analysts, with shifts away from more favorable recommendations. This trend may mirror wider economic expectations or sector-specific concerns.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-07-28 | Neutral | Overweight | Cantor Fitzgerald |
| 2025-07-23 | Equal Weight | Overweight | Wells Fargo |
| 2025-07-21 | Hold | Buy | TD Cowen |
| 2025-07-16 | Underperform | Neutral | B of A Securities |
| 2025-07-10 | Equal Weight | Overweight | Morgan Stanley |
Interpretation
The analysis of Centene Corporation suggests a cautious market sentiment, with analysts showing a reduced enthusiasm towards aggressive buying. The increase in hold ratings and a decrease in strong buy recommendations point towards growing uncertainty. While there may not be any immediate triggers for drastic changes, it is apparent that the market's evaluation remains conservative with a focus on potential risk factors. The stability of recent neutral to hold ratings reflects a shift towards caution.
Conclusion
Centene Corporation finds itself in a landscape where analysts have adopted a more conservative outlook. Although the company continues to operate within a promising market space, the recent ratings downgrade highlights apprehension about near-term potentials. With analysts leaning towards hold recommendations, there seems to be an acknowledgment of risks and a wait-and-see approach. The current sentiment underscores the importance for investors to weigh opportunities against prevailing market uncertainties.